| CPSC | congenital paucity of secondary synaptic clefts [syndrome]; Consumer Products Safety Commission |
|---|---|
| ERPC | evacuation of retained products of conception |
| FbDP | fibrin degradation products |
| FgDP | fibrinogen degradation products |
| SPF | skin protection factor; specific-pathogen free; spectrophotofluorometer; S-phase fraction; split pro... |
| waste products | Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. (12 Dec 1998) |
|---|---|
| conventional forest products | Any commercial roundwood product (boards, dimension lumber, pulp and paper products) except fuelwood. (05 Dec 1998) |
| poultry products | Food products manufactured from poultry. (12 Dec 1998) |
| household products | Substances or materials used in the course of housekeeping or personal routine. (12 Dec 1998) |
| specialty chemicals and products | Chemicals and chemical products used in a research, industrial, or household setting. Included here are the specific drug preparations, as well as the substances involved in the manufacture and stabilization of pharmaceutical preparations and agricultural agents. (12 Dec 1998) |
| natural products | Naturally occurring compounds that are end products of secondary metabolism; often, they are unique compounds for particular organisms or classes of organisms. (05 Mar 2000) |
| dairy products | Raw and processed or manufactured milk and milk-derived products. These are usually from cows (bovine) but are also from goats, sheep, reindeer, and water buffalo. (12 Dec 1998) |
| orphan products | Drugs, biologicals, and medical devices (including diagnostic in vitro tests) that may be useful in common or rare diseases but which are not considered commercially viable. Synonym: orphan drugs. (05 Mar 2000) |
| fibrin degradation products | <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot. Normal value is less than 10 mcg/ml (micrograms per millilitre). They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia. Acronym: FDP (23 Sep 2002) |
| fibrin fibrinogen degradation products | <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis. Pharmacological action: antithrombins. (12 Dec 1998) |
| fish products | Food products manufactured from fish (e.g., fish flour, fish meal). (12 Dec 1998) |
| vaginal | 1. Of the nature of a sheath, ensheathing. 2. <anatomy> Pertaining to the vagina. 3. Pertaining to the tunica vaginalis testis. (18 Nov 1997) |
| vaginal artery | <anatomy, artery> Origin, internal iliac; distribution, vagina, base of bladder, rectum; anastomoses, uterine, internal pudendal. Synonym: arteria vaginalis. (05 Mar 2000) |
| vaginal atresia | Congenital or acquired imperforation or occlusion of the vagina, or adhesion of the walls of the vagina. Synonym: ankylocolpos, colpatresia. (05 Mar 2000) |
| vaginal birth after cesarean | Delivery of an infant through the vagina in a female who has had a prior cesarean section. (12 Dec 1998) |